Beyond Tuberculosis: Unlocking the Antifungal Potential of Novel Isoniazid Derivatives against Non-Candida albicans Candida Species.

Mokoto TML, Setshedi IB

Open source

DOI
10.1021/acsomega.6c00859
Published
2026 Sep 22
Container
ACS omega
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acsomega.6c00859,
  title = {Beyond Tuberculosis: Unlocking the Antifungal Potential of Novel Isoniazid Derivatives against Non-Candida albicans Candida Species.},
  author = {Mokoto TML and Setshedi IB},
  year = {2026},
  journal = {ACS omega},
  doi = {10.1021/acsomega.6c00859},
  url = {https://doi.org/10.1021/acsomega.6c00859}
}

RIS

TY  - JOUR
TI  - Beyond Tuberculosis: Unlocking the Antifungal Potential of Novel Isoniazid Derivatives against Non-Candida albicans Candida Species.
AU  - Mokoto TML
AU  - Setshedi IB
PY  - 2026
JO  - ACS omega
DO  - 10.1021/acsomega.6c00859
UR  - https://doi.org/10.1021/acsomega.6c00859
ER  - 

APA

TML, M., & IB, S. (2026). Beyond Tuberculosis: Unlocking the Antifungal Potential of Novel Isoniazid Derivatives against Non-Candida albicans Candida Species.. ACS omega. https://doi.org/10.1021/acsomega.6c00859

Source records